MicroRNA-mediated resistance to anti-PD1 therapy in lung cancer

被引：0
|
作者：
Cortez, Maria A.
Wang, Xiaohong
Ivan, Cristina
Schoenhals, Jonathan E.
Niknam, Sharareh
Li, Ailin
Valdecanas, David
Allison, James P.
Sharma, Padmanee
Overwijk, Willem W.
Gomez, Daniel
Chang, Joey Y.
Hahn, Stephen
Calin, George A.
Welsh, James W.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
569
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Anti-Ma2/Ta paraneoplastic rhombencephalitis in a patient with lung cancer responsive to anti-PD1 therapy
    Leempoel, Jonathan
    Ruyssen, Antoine
    Kessler, Roger
    Van Pesch, Vincent
    Gille, Michel
    ACTA NEUROLOGICA BELGICA, 2020, 120 (02) : 451 - 452
  • [22] Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy
    Qiaoyun Tan
    Liyuan Dai
    Yanrong Wang
    Shuxia Liu
    Te Liang
    Rongrong Luo
    Shasha Wang
    Ning Lou
    Haizhu Chen
    Yu Zhou
    Qiaofeng Zhong
    Jianliang Yang
    Puyuan Xing
    Xingsheng Hu
    Yutao Liu
    Shengyu Zhou
    Jiarui Yao
    Di Wu
    Zhishang Zhang
    Le Tang
    Xiaobo Yu
    Xiaohong Han
    Yuankai Shi
    Cancer Immunology, Immunotherapy, 2022, 71 : 1681 - 1691
  • [23] Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy
    Tan, Qiaoyun
    Dai, Liyuan
    Wang, Yanrong
    Liu, Shuxia
    Liang, Te
    Luo, Rongrong
    Wang, Shasha
    Lou, Ning
    Chen, Haizhu
    Zhou, Yu
    Zhong, Qiaofeng
    Yang, Jianliang
    Xing, Puyuan
    Hu, Xingsheng
    Liu, Yutao
    Zhou, Shengyu
    Yao, Jiarui
    Wu, Di
    Zhang, Zhishang
    Tang, Le
    Yu, Xiaobo
    Han, Xiaohong
    Shi, Yuankai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (07) : 1681 - 1691
  • [24] Resistance to anti-PD1 therapies in patients with advanced melanoma: systematic literature review and application of the Society for Immunotherapy of Cancer Immunotherapy Resistance Taskforce anti-PD1 resistance definitions
    Shui, Irene M.
    Scherrer, Emilie
    Frederickson, Andrew
    Li, Joyce W.
    Mynzhassarova, Anel
    Druyts, Eric
    Tawbi, Hussein
    MELANOMA RESEARCH, 2022, 32 (06) : 393 - 404
  • [25] Overcome LKB1 mutated cancer resistance to anti-PD1 treatment
    Deng, Jiehui
    Thennavan, Aatish
    Pan, Yuanwang
    Dolgalev, Igor
    Chen, Ting
    Silver, Heather
    Harris, Matthew
    Pyon, Val
    Li, Fei
    Lee, Chelsea
    Tsirigos, Aristotelis
    Rothenberg, Eli
    Perou, Charles M.
    Wong, Kwok-Kin
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Interrogating anti-PD1 immunotherapy resistance mechanisms
    Uppaluri, Ravindra
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 21 - 21
  • [27] Amplifying T cell-mediated antitumor immune responses in nonsmall cell lung cancer through photodynamic therapy and anti-PD1
    Gong, Beilei
    Wang, Liping
    Zhang, Han
    Wang, Qingkai
    Li, Wei
    CELL BIOCHEMISTRY AND FUNCTION, 2024, 42 (01)
  • [28] Clinical analysis of patients (pts) with Lung cancer treated with anti-PD1/PDL1 therapy.
    Tian, Kaihua
    Wang, Xintong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer
    Guisier, Florian
    Cousse, Stephanie
    Jeanvoine, Mathilde
    Thiberville, Luc
    Salaun, Mathieu
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] Lung Microbiota Influence Responses to Anti-PD1 Therapy in a Preclinical Model of Non-small Cell Lung Cancer
    Chang, M.
    Mccormick, C.
    Kwok, B.
    Li, Y.
    Kyeremateng, Y.
    Aktas, A.
    Singh, R.
    Singh, S.
    Li, Q.
    Kugler, M. C.
    Pass, H.
    Sterman, D. H.
    Wu, B. G.
    Segal, L. N.
    Tsay, J. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345